TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Uroderma AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,055
|
958
|
890 |
| Financial expenses |
1
|
0
|
0 |
| Earnings before taxes |
497
|
490
|
366 |
| EBITDA |
516
|
511
|
402 |
| Total assets |
924
|
882
|
743 |
| Current assets |
397
|
410
|
501 |
| Current liabilities |
77
|
162
|
181 |
| Equity capital |
847
|
720
|
562 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
91.7%
|
81.6%
|
75.6% |
| Turnover per employee |
352
|
319
|
297 |
| Profit as a percentage of turnover |
47.1%
|
51.1%
|
41.1% |
| Return on assets (ROA) |
53.9%
|
55.6%
|
49.3% |
| Current ratio |
515.6%
|
253.1%
|
276.8% |
| Return on equity (ROE) |
58.7%
|
68.1%
|
65.1% |
| Change turnover |
94
|
140
|
199 |
| Change turnover % |
10%
|
17%
|
29% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.